Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
28.84
-0.26 (-0.89%)
At close: Oct 16, 2026, 4:00 PM EDT
28.37
-0.47 (-1.64%)
After-hours: Oct 16, 2026, 7:58 PM EDT
Arcutis Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $48 | Buy | Initiates | $48 | +66.44% | Oct 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $34 | Buy | Reiterates | $34 | +17.89% | Aug 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $34 → $38 | Buy | Reiterates | $34 → $38 | +31.76% | Aug 6, 2026 |
| Needham | Needham | Buy Reiterates $40 | Buy | Reiterates | $40 | +38.70% | Aug 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $35 → $38 | Buy | Reiterates | $35 → $38 | +31.76% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $35 | Buy | Maintains | $35 | +21.36% | Aug 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $35 | Buy | Maintains | $35 | +21.36% | Jul 9, 2026 |